Trials / Terminated
TerminatedNCT00322712
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- University of New Mexico · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chart Review of patients with pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.
Detailed description
Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.
Conditions
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2006-12-01
- Completion
- 2007-01-01
- First posted
- 2006-05-08
- Last updated
- 2024-02-05
- Results posted
- 2015-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00322712. Inclusion in this directory is not an endorsement.